Literature DB >> 22508623

Localization of inflammatory mediators in pediatric sinus mucosa.

Xiaofang Wu1, Remy Mimms, Roberta Lima, Jennifer Peters-Hall, Mary C Rose, Maria T Peña.   

Abstract

OBJECTIVES: Microarray analyses of sinus mucosa in pediatric patients with chronic rhinosinusitis (CRS) have recently demonstrated increased messenger RNA expression of the inflammatory chemokines CXCL5 and CXCL13 and of the innate immune mediators β-defensin 1 (DEFB1), serum amyloid A2 (SAA2), and serpin B4. The objectives of this study were to determine whether these gene products were expressed at the protein level in pediatric sinus mucosa and to determine their localization.
DESIGN: Immunohistochemical analysis was used to identify protein expression and cellular localization of CXCL5, CXCL13, DEFB1, SAA2, and serpin B4. Coimmunofluorescence staining of inflammatory cells was performed to further evaluate expression of CXCL5 and CXCL13.
SETTING: Pediatric tertiary care facility. PATIENTS: Fifteen children with CRS who underwent endoscopic sinus surgery and 8 children who underwent craniofacial or neurosurgical procedures for abnormalities other than sinusitis. MAIN OUTCOME MEASURES: Protein expression and cellular localization of CXCL5, CXCL13, DEFB1, SAA2, and serpin B4 in pediatric sinus mucosa.
RESULTS: Ciliated and basal cells in the pseudostratified epithelium stained positively for the 5 mediators examined in both cohorts. Except for serpin B4, goblet cells did not stain for any mediators in either cohort. Glandular cells stained positively for all 5 mediators in both cohorts. Coimmunofluorescence staining of inflammatory cells showed that CXCL13 was expressed in macrophages, T and B cells but not in neutrophils. CXCL5 was detected only in T cells.
CONCLUSIONS: CXCL5, CXCL13, DEFB1, SAA2, and serpin B4 were expressed at the protein level in the sinus mucosa of controls and pediatric patients with CRS and exhibited cell-specific localization. These mediators, not typically associated with pediatric CRS, may be involved in the inflammatory response and mucus hypersecretion seen in pediatric CRS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508623      PMCID: PMC4497780          DOI: 10.1001/archoto.2012.155

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  20 in total

1.  CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

Authors:  K Mark Ansel; Ruth B S Harris; Jason G Cyster
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

Review 2.  Innate immunity in the lung: how epithelial cells fight against respiratory pathogens.

Authors:  R Bals; P S Hiemstra
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

3.  Mucus production in chronic maxillary sinusitis. A quantitative histopathological study.

Authors:  M Tos; C Mogensen
Journal:  Acta Otolaryngol       Date:  1984 Jan-Feb       Impact factor: 1.494

4.  Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids.

Authors:  C M Lennard; E A Mann; L L Sun; A S Chang; W E Bolger
Journal:  Am J Rhinol       Date:  2000 Nov-Dec

5.  Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase.

Authors:  C Schick; Y Kamachi; A J Bartuski; S Cataltepe; N M Schechter; P A Pemberton; G A Silverman
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

Review 6.  Pediatric rhinosinusitis.

Authors:  R P Lusk; J A Stankiewicz
Journal:  Otolaryngol Head Neck Surg       Date:  1997-09       Impact factor: 5.591

7.  Production of beta-defensins by human airway epithelia.

Authors:  P K Singh; H P Jia; K Wiles; J Hesselberth; L Liu; B A Conway; E P Greenberg; E V Valore; M J Welsh; T Ganz; B F Tack; P B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Quantification for staging sinusitis. The Staging and Therapy Group.

Authors:  V J Lund; D W Kennedy
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1995-10

9.  Expression profiling of inflammatory mediators in pediatric sinus mucosa.

Authors:  Xiaofang Wu; Svetlana Ghimbovschi; Pawandeep K Aujla; Mary C Rose; Maria T Peña
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-01

10.  Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis.

Authors:  Monica Patadia; Julian Dixon; David Conley; Rakesh Chandra; Anju Peters; Lydia A Suh; Atsushi Kato; Roderick Carter; Kathleen Harris; Leslie Grammer; Robert Kern; Robert Schleimer
Journal:  Am J Rhinol Allergy       Date:  2010 Jan-Feb       Impact factor: 2.467

View more
  3 in total

1.  ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages.

Authors:  Janice A Layhadi; Jeremy Turner; David Crossman; Samuel J Fountain
Journal:  J Immunol       Date:  2017-12-18       Impact factor: 5.422

Review 2.  Low-dose macrolides for treating pediatric rhinosinusitis: A retrospective study and literature review.

Authors:  Kachorn Seresirikachorn; Thad Chetthanon; Teerapat Suwansirisuk; Songklot Aeumjaturapat; Supinda Chusakul; Jesada Kanjanaumporn; Kornkiat Snidvongs
Journal:  SAGE Open Med       Date:  2020-06-30

3.  Characteristic expression and significance of CCL19 in different tissue types in chronic rhinosinusitis.

Authors:  You Zou; Yan Wang; Shui-Bin Wang; Yong-Gang Kong; Y U Xu; Ze-Zhang Tao; Shi-Ming Chen
Journal:  Exp Ther Med       Date:  2015-11-26       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.